↓ Skip to main content

Dove Medical Press

Stem Cell Therapy for Retinal Degeneration: The Evidence to Date

Overview of attention for article published in Biologics: Targets & Therapy, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
10 X users
facebook
2 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
77 Mendeley
Title
Stem Cell Therapy for Retinal Degeneration: The Evidence to Date
Published in
Biologics: Targets & Therapy, July 2021
DOI 10.2147/btt.s290331
Pubmed ID
Authors

Amit Sharma, Bithiah Grace Jaganathan

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 14%
Student > Ph. D. Student 10 13%
Student > Bachelor 8 10%
Student > Doctoral Student 2 3%
Student > Postgraduate 2 3%
Other 6 8%
Unknown 38 49%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 13%
Medicine and Dentistry 8 10%
Neuroscience 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Chemistry 2 3%
Other 6 8%
Unknown 41 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#4,258,310
of 25,392,582 outputs
Outputs from Biologics: Targets & Therapy
#53
of 284 outputs
Outputs of similar age
#95,055
of 453,590 outputs
Outputs of similar age from Biologics: Targets & Therapy
#3
of 14 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,590 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.